Novacyt SA
F:NYZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novacyt SA
F:NYZ
|
FR |
|
Derichebourg SA
PAR:DBG
|
FR |
|
Sandvik AB
F:SVK
|
SE |
|
Industrias Penoles SAB de CV
F:4FO
|
MX |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
P
|
PT Royaltama Mulia Kontraktorindo Tbk
IDX:RMKO
|
ID |
|
D
|
Dampskibsselskabet Norden A/S
DUS:D69
|
DK |
|
R
|
Rio Tinto Ltd
SWB:CRA1
|
AU |
|
A
|
AnaptysBio Inc
F:AN6
|
US |
|
Noxopharm Ltd
ASX:NOX
|
AU |
|
Nufarm Ltd
ASX:NUF
|
AU |
|
P
|
Phaos Technology Holdings (Cayman) Limited
AMEX:POAS
|
SG |
|
A
|
Anhui Conch Cement Co Ltd
XMUN:AQE
|
CN |
|
L
|
Lululemon Athletica Inc
XBER:33L
|
CA |
|
Tauron Polska Energia SA
F:1T5
|
PL |
|
Asian Television Network International Ltd
XTSX:SAT
|
CA |
|
Revenio Group Oyj
F:R0V
|
FI |
Bankruptcy Probability
Novacyt SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novacyt SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Novacyt SA
PAR:ALNOV
|
22.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
107.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
74.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novacyt SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novacyt SA has total debt of 10m GBP. This includes both short-term (0 GBP) and long-term (10m GBP) debt.
You can find a full breakdown on its Balance Sheet.
